Association between prognosis and the use of angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blocker in frail patients with heart failure with preserved ejection fraction

27 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: Heart failure with preserved ejection fraction (HFpEF) 1 Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by